Bradford Georgia, Asgari Behnoush, Smit Bronwyn, Hatje Eva, Kuballa Anna, Katouli Mohammad
School of Science, Technology and Education, and Centre for Bioinnovation, University of the Sunshine Coast, Maroochydore DC, QLD 4558, Australia.
School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4000, Australia.
Microorganisms. 2024 Feb 29;12(3):502. doi: 10.3390/microorganisms12030502.
The gastrointestinal tract's microbiota plays a crucial role in human health, with dysbiosis linked to the development of diseases such as inflammatory bowel disease (IBD). Whilst the pathogenic mechanisms underlying IBD remain poorly characterised, adherent-invasive (AIEC) has been implicated as a microbiological factor in disease pathogenesis. These strains show an enhanced ability to diffusely adhere to and invade intestinal epithelial cells, along with the ability to survive and replicate within macrophages. Probiotics, such as strains, have been identified as potential treatment options due to their abilities to compete with pathogens for binding sites and regulate the host immune response. In this study, we used four well-characterised strains and their combination to test their ability to inhibit the adhesion, invasion, and translocation of a well-characterized AIEC strain, F44A-1, in a co-culture of Caco-2 and HT29-MTX cell lines representing the gut epithelium. The results demonstrated that the pre-inoculation of the probiotic candidates 90 min prior to the introduction of the AIEC was more effective in inhibiting AIEC interaction than the co-inoculation of the strains. While the individual probiotic strains greatly reduced AIEC colonisation and invasion of the co-cultured cells, their combination was only more effective in reducing the translocation of the AIEC. These results suggest that probiotics are more effective when used prophylactically against pathogens and that the combination of strains may enhance their efficacy against AIEC translocation once used as a prophylactic measure.
胃肠道微生物群在人类健康中起着至关重要的作用,微生物群失调与炎症性肠病(IBD)等疾病的发生有关。虽然IBD的致病机制仍不清楚,但黏附侵袭性大肠杆菌(AIEC)被认为是疾病发病机制中的一个微生物因素。这些菌株表现出更强的扩散黏附并侵袭肠道上皮细胞的能力,以及在巨噬细胞内存活和复制的能力。益生菌,如某些菌株,因其能够与病原体竞争结合位点并调节宿主免疫反应,已被确定为潜在的治疗选择。在本研究中,我们使用了四株特性明确的菌株及其组合,在代表肠道上皮的Caco-2和HT29-MTX细胞系共培养物中,测试它们抑制一株特性明确的AIEC菌株F44A-1黏附、侵袭和易位的能力。结果表明,在引入AIEC前90分钟预先接种益生菌候选菌株,比同时接种这些菌株更有效地抑制AIEC的相互作用。虽然单个益生菌菌株大大减少了AIEC在共培养细胞中的定植和侵袭,但它们的组合仅在减少AIEC易位方面更有效。这些结果表明,益生菌在预防性对抗病原体时更有效,并且一旦用作预防措施,菌株组合可能会增强其对AIEC易位的疗效。